Uhlmann Price Securities LLC Acquires New Shares in Ventas, Inc. $VTR

Uhlmann Price Securities LLC acquired a new position in shares of Ventas, Inc. (NYSE:VTRFree Report) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 7,659 shares of the real estate investment trust’s stock, valued at approximately $629,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in Ventas by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock worth $5,876,856,000 after purchasing an additional 2,349,176 shares in the last quarter. State Street Corp increased its position in shares of Ventas by 2.5% in the fourth quarter. State Street Corp now owns 29,662,635 shares of the real estate investment trust’s stock valued at $2,309,234,000 after buying an additional 735,620 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Ventas by 3.8% during the 4th quarter. Geode Capital Management LLC now owns 12,988,943 shares of the real estate investment trust’s stock worth $1,001,447,000 after buying an additional 475,633 shares during the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Ventas by 27.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 9,176,254 shares of the real estate investment trust’s stock worth $710,060,000 after buying an additional 2,000,341 shares during the last quarter. Finally, Capital World Investors purchased a new stake in shares of Ventas in the 4th quarter worth about $594,116,000. 94.18% of the stock is owned by institutional investors and hedge funds.

Ventas Stock Up 0.0%

VTR opened at $81.61 on Friday. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95. The firm has a market cap of $39.68 billion, a P/E ratio of 148.38, a PEG ratio of 1.75 and a beta of 0.71. Ventas, Inc. has a 52 week low of $61.76 and a 52 week high of $91.06. The business’s fifty day simple moving average is $85.07 and its 200 day simple moving average is $82.58.

Ventas (NYSE:VTRGet Free Report) last posted its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The company had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the prior year, the business posted $0.84 EPS. The company’s revenue for the quarter was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, equities research analysts anticipate that Ventas, Inc. will post 3.88 EPS for the current fiscal year.

Ventas Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.52 per share. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. Ventas’s payout ratio is 378.18%.

Wall Street Analyst Weigh In

VTR has been the topic of a number of research reports. Scotiabank lowered their price objective on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating on the stock in a research note on Thursday. Jefferies Financial Group lifted their target price on shares of Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Ventas in a report on Friday, March 27th. Evercore reiterated an “outperform” rating and issued a $95.00 price target on shares of Ventas in a research report on Wednesday, April 29th. Finally, Wells Fargo & Company raised their price objective on shares of Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research note on Monday, June 1st. Fifteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Ventas currently has an average rating of “Moderate Buy” and an average price target of $96.00.

Read Our Latest Analysis on VTR

Insider Transactions at Ventas

In related news, Director Walter C. Rakowich sold 1,152 shares of the company’s stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the transaction, the director owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. This represents a 3.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler bought 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were purchased at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the transaction, the director owned 19,202 shares of the company’s stock, valued at $1,513,309.62. The trade was a 14.97% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 0.53% of the company’s stock.

Ventas Profile

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Further Reading

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTRFree Report).

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.